268 related articles for article (PubMed ID: 22644781)
1. Phosphorylation of signal transducer and activator of transcription 3 in soft tissue leiomyosarcoma is associated with a better prognosis.
Setsu N; Kohashi K; Endo M; Yamamoto H; Tamiya S; Takahashi Y; Yamada Y; Ishii T; Matsuda S; Yokoyama R; Iwamoto Y; Oda Y
Int J Cancer; 2013 Jan; 132(1):109-15. PubMed ID: 22644781
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in human cutaneous melanoma.
Wu ZS; Cheng XW; Wang XN; Song NJ
Melanoma Res; 2011 Dec; 21(6):483-90. PubMed ID: 21876460
[TBL] [Abstract][Full Text] [Related]
3. PIAS3, SHP2 and SOCS3 Expression patterns in Cervical Cancers: Relevance with activation and resveratrol-caused inactivation of STAT3 signaling.
Zhang P; Yang B; Yao YY; Zhong LX; Chen XY; Kong QY; Wu ML; Li C; Li H; Liu J
Gynecol Oncol; 2015 Dec; 139(3):529-35. PubMed ID: 26432044
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of STAT3 in Undifferentiated Pleomorphic Sarcoma Is Correlated with a Favorable Prognosis.
Bekki H; Kohashi K; Yamada Y; Iura K; Ishii T; Maekawa A; Otsuka H; Yamamoto H; Hakozaki M; Nabeshima K; Iwamoto Y; Oda Y
Pathobiology; 2017; 84(3):161-169. PubMed ID: 27652596
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 11 signaling components signal transducer and activator of transcription 3 (STAT3) and suppressor of cytokine signaling 3 (SOCS3) regulate human endometrial stromal cell differentiation.
Dimitriadis E; Stoikos C; Tan YL; Salamonsen LA
Endocrinology; 2006 Aug; 147(8):3809-17. PubMed ID: 16709613
[TBL] [Abstract][Full Text] [Related]
6. Correlative analyses of the expression levels of PIAS3, p-SHP2, SOCS1 and SOCS3 with STAT3 activation in human astrocytomas.
Liu LH; Li H; Cheng XX; Kong QY; Chen XY; Wu ML; Li Y; Liu J; Li C
Mol Med Rep; 2017 Feb; 15(2):847-852. PubMed ID: 28035384
[TBL] [Abstract][Full Text] [Related]
7. Suppressor of cytokine signaling 3 expression in anaplastic large cell lymphoma.
Cho-Vega JH; Rassidakis GZ; Amin HM; Tsioli P; Spurgers K; Remache YK; Vega F; Goy AH; Gilles F; Medeiros LJ
Leukemia; 2004 Nov; 18(11):1872-8. PubMed ID: 15385932
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional repression of SOCS3 mediated by IL-6/STAT3 signaling via DNMT1 promotes pancreatic cancer growth and metastasis.
Huang L; Hu B; Ni J; Wu J; Jiang W; Chen C; Yang L; Zeng Y; Wan R; Hu G; Wang X
J Exp Clin Cancer Res; 2016 Feb; 35():27. PubMed ID: 26847351
[TBL] [Abstract][Full Text] [Related]
9. Forkhead box protein 3 in human nasal polyp regulatory T cells is regulated by the protein suppressor of cytokine signaling 3.
Lan F; Zhang N; Zhang J; Krysko O; Zhang Q; Xian J; Derycke L; Qi Y; Li K; Liu S; Lin P; Bachert C
J Allergy Clin Immunol; 2013 Dec; 132(6):1314-21. PubMed ID: 23910692
[TBL] [Abstract][Full Text] [Related]
10. Expression of signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 in urothelial carcinoma.
Huang WT; Yang SF; Wu CC; Chen WT; Huang YC; Su YC; Chai CY
Kaohsiung J Med Sci; 2009 Dec; 25(12):640-6. PubMed ID: 19951849
[TBL] [Abstract][Full Text] [Related]
11. Signal transducer and activator of transcription 3 (STAT3) and Suppressor of Cytokine Signaling (SOCS3) balance controls cytotoxicity and IL-10 expression in decidual-like natural killer cell line NK-92.
Braunschweig A; Poehlmann TG; Busch S; Schleussner E; Markert UR
Am J Reprod Immunol; 2011 Oct; 66(4):329-35. PubMed ID: 21385272
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of the JAK/STAT pathway by LIF and OSM in the human granulosa cell line COV434.
Pastuschek J; Poetzsch J; Morales-Prieto DM; Schleußner E; Markert UR; Georgiev G
J Reprod Immunol; 2015 Apr; 108():48-55. PubMed ID: 25817464
[TBL] [Abstract][Full Text] [Related]
13. Reduced phosphorylation of Stat3 at Ser-727 mediated by casein kinase 2 - protein phosphatase 2A enhances Stat3 Tyr-705 induced tumorigenic potential of glioma cells.
Mandal T; Bhowmik A; Chatterjee A; Chatterjee U; Chatterjee S; Ghosh MK
Cell Signal; 2014 Aug; 26(8):1725-34. PubMed ID: 24726840
[TBL] [Abstract][Full Text] [Related]
14. Expression of the JAK/STAT3/SOCS3 signaling pathway in herniated lumbar discs.
Osuka K; Usuda N; Aoyama M; Yamahata H; Takeuchi M; Yasuda M; Takayasu M
Neurosci Lett; 2014 May; 569():55-8. PubMed ID: 24686183
[TBL] [Abstract][Full Text] [Related]
15. High suppressor of cytokine signaling-3 expression impairs STAT3-dependent protective effects of interleukin-22 in ulcerative colitis in remission.
Xu AT; Li Y; Zhao D; Shen J; Xu XT; Qiao YQ; Zhu MM; Wang TR; Cui Y; Ai LY; Ran ZH
Inflamm Bowel Dis; 2015 Feb; 21(2):241-50. PubMed ID: 25545374
[TBL] [Abstract][Full Text] [Related]
16. The Akt/mammalian target of rapamycin pathway is activated and associated with adverse prognosis in soft tissue leiomyosarcomas.
Setsu N; Yamamoto H; Kohashi K; Endo M; Matsuda S; Yokoyama R; Nishiyama K; Iwamoto Y; Dobashi Y; Oda Y
Cancer; 2012 Mar; 118(6):1637-48. PubMed ID: 21837670
[TBL] [Abstract][Full Text] [Related]
17. Human epidermal growth factor receptor 2 expressions and Janus-activated kinase/signal transducer and activator of transcription 3-suppressor of cytokine signaling 3 pathway may be associated with clinicopathological features and prognosis of gastric cancer.
Xu W; Fu J; Wu H; Sun W
J Cancer Res Ther; 2018 Jun; 14(Supplement):S311-S318. PubMed ID: 29970682
[TBL] [Abstract][Full Text] [Related]
18. SHP2, SOCS3 and PIAS3 Expression Patterns in Medulloblastomas: Relevance to STAT3 Activation and Resveratrol-Suppressed STAT3 Signaling.
Li C; Li H; Zhang P; Yu LJ; Huang TM; Song X; Kong QY; Dong JL; Li PN; Liu J
Nutrients; 2016 Dec; 9(1):. PubMed ID: 28035977
[TBL] [Abstract][Full Text] [Related]
19. Impact of STAT3 phosphorylation on the clinical effectiveness of anti-EGFR-based therapy in patients with metastatic colorectal cancer.
Dobi E; Monnien F; Kim S; Ivanaj A; N'Guyen T; Demarchi M; Adotevi O; Thierry-Vuillemin A; Jary M; Kantelip B; Pivot X; Godet Y; Degano SV; Borg C
Clin Colorectal Cancer; 2013 Mar; 12(1):28-36. PubMed ID: 23083634
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the SOCS3 promoter response to prostaglandin E2 in T47D cells.
Barclay JL; Anderson ST; Waters MJ; Curlewis JD
Mol Endocrinol; 2007 Oct; 21(10):2516-28. PubMed ID: 17636039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
